Clinical features of kidney cancer in primary care: a case-control study using primary care records
Authors:
- Elizabeth ShephardESElizabeth Shephard
- Richard NealRNRichard Neal
- Peter RosePRPeter Rose
- Fiona WalterFWFiona Walter
- William T HamiltonWHWilliam T Hamilton
Open Access
- 1 April 2013
- journal article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 63 (609) , e250-e255
Abstract
Background Kidney cancer accounts for over 4000 UK deaths annually, and is one of the cancer sites with a poor mortality record compared with Europe. Aim To identify and quantify all clinical features of kidney cancer in primary care. Design Case-control study, using General Practice Research Database records. Method A total of 3149 patients aged ≥40 years, diagnosed with kidney cancer between 2000 and 2009, and 14 091 age, sex and practice-matched controls, were selected. Clinical features associated with kidney cancer were identified, and analysed using conditional logistic regression. Positive predictive values for features of kidney cancer were estimated. Results Cases consulted more frequently than controls in the year before diagnosis: median 16 consultations (interquartile range 10–25) versus 8 (4–15): P<0.001. Fifteen features were independently associated with kidney cancer: visible haematuria, odds ratio 37 (95% confidence interval [CI] = 28 to 49), abdominal pain 2.8 (95% CI = 2.4 to 3.4), microcytosis 2.6 (95% CI = 1.9 to 3.4), raised inflammatory markers 2.4 (95% CI = 2.1 to 2.8), thrombocytosis 2.2 (95% CI = 1.7 to 2.7), low haemoglobin 1.9 (95% CI = 1.6 to 2.2), urinary tract infection 1.8 (95% CI = 1.5 to 2.1), nausea 1.8 (95% CI = 1.4 to 2.3), raised creatinine 1.7 (95% CI = 1.5 to 2.0), leukocytosis 1.5 (95% CI = 1.2 to 1.9), fatigue 1.5 (95% CI = 1.2 to 1.9), constipation 1.4 (95% CI = 1.1 to 1.7), back pain 1.4 (95% CI = 1.2 to 1.7), abnormal liver function 1.3 (95% CI = 1.2 to 1.5), and raised blood sugar 1.2 (95% CI = 1.1 to 1.4). The positive predictive value for visible haematuria in patients aged ≥60 years was 1.0% (95% CI = 0.8 to 1.3). Conclusion Visible haematuria is the commonest and most powerful single predictor of kidney cancer, and the risk rises when additional symptoms are present. When considered alongside the risk of bladder cancer, the overall risk of urinary tract cancer from haematuria warrants referral.Keywords
This publication has 17 references indexed in Scilit:
- Clinical features of bladder cancer in primary careBritish Journal of General Practice, 2012
- Cancer diagnosis in UK primary careNature Reviews Clinical Oncology, 2012
- Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic studyBritish Journal of General Practice, 2011
- Clinical features of primary brain tumours: a case-control study using electronic primary care records.2007
- Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research DatabaseBMJ, 2007
- Clinical features of colorectal cancer before diagnosis: a population-based case–control studyBritish Journal of Cancer, 2005
- Systematic review of scope and quality of electronic patient record data in primary careBMJ, 2003
- The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice.2003
- Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies.2002
- Obesity and renal cell cancer – a quantitative reviewBritish Journal of Cancer, 2001